Compare Ginkgo Bioworks Holdings Inc (DNA) vs Tesla, Inc. (TSLA) Price & Performance

Ginkgo Bioworks Holdings IncTrade

Tesla, Inc.Trade

Price performance (Past 24H)

Key statistics

Ginkgo Bioworks Holdings Inc vs Tesla, Inc. — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while Tesla, Inc. trades at $333.91 (market cap $1.31T). The key difference: Tesla, Inc. is far larger — about 2590.3× Ginkgo Bioworks Holdings Inc's market cap. Which is the better fit depends on your goals.

	DNA	TSLA
Market Cap	$505.73M	$1.31T
Sector	Health	Consumer Cyclical
52-Week High	$16.14	$489.88
52-Week Low	$5.48	$298.16
Enterprise Value	$607.68M	$1.29T

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ginkgo Bioworks Holdings Inc

No Aura AI signal available yet.

Tesla, Inc.

Tesla (TSLA) trades at $330.87, up 0.7% on the day, with a bearish technical signal from moving averages and a mixed fundamental picture. The stock shows high valuation multiples (P/E 308.16, P/S 11.36) amid declining profitability, with net income margin falling to 3.67% in 2025 from 15.49% in 2023. Recent news highlights regulatory approval for self-driving software in Europe and a potential cheaper EV model, but Q2 2026 earnings missed expectations.

Outlook remains polarized: analyst consensus price target of $393.87 suggests 19% upside, but high valuation and margin compression pose risks. Key catalysts include autonomy advancements and energy/robotics growth, while competition and execution challenges weigh on sentiment. The stock's trajectory hinges on delivering AI-driven revenue streams beyond automotive.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DNA

View details →

TSLA

Investor Ron Baron predicts SpaceX could reach a $40 trillion valuation in 15 years, echoing his successful Tesla bet.24/7 Wall Street · 4 hours agoBullish Tesla shares fall 26% YTD, seen overvalued at $333 amid weak margins and costly growth bets.24/7 Wall Street · 5 hours agoBearish Tesla CEO Musk's 2025 pay plan could skip milestones if Tesla is acquired, potentially unlocking $824B payout.24/7 Wall Street · 5 hours agoNeutral View details →

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.

About Tesla, Inc.

Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.